Mengda Xu
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
- Surgery 3
- Hydrogen's biological and therapeutic effects 1
- Cholesterol and Lipid Metabolism 1
- Co-authors
- Bixi Li (4 shared papers)Xiaoyang Song (4 shared papers)Xiang Zhou (3 shared papers)Fang Liu (1 shared paper)Juan Wu (1 shared paper)Li Lin (1 shared paper)Changli Wang (4 shared papers)Xiaoming Deng (3 shared papers)
- Journals
- Scientific Reports (1 paper)Virology Journal (1 paper)Experimental & Molecular Medicine (1 paper)Journal of Molecular Histology (1 paper)CyTA - Journal of Food (1 paper)
- Partner nations
- China
In The Last Decade
Mengda Xu
9 papers receiving 932 citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Infectious Diseases 643
- Neurology 341
- Critical Care and Intensive Care Medicine 53
- Dermatology 47
- Epidemiology 174
Countries citing papers authored by Mengda Xu
This map shows the geographic impact of Mengda Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengda Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengda Xu more than expected).
Fields of papers citing papers by Mengda Xu
This network shows the impact of papers produced by Mengda Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengda Xu. The network helps show where Mengda Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Mengda Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19 Hit paper breakdown → | 2020 | 765 |
| 2 | 2019 | 92 | |
| 3 | 2017 | 35 | |
| 4 | 2018 | 17 | |
| 5 | 2021 | 16 | |
| 6 | 2019 | 14 | |
| 7 | 2023 | 11 | |
| 8 | 2022 | 8 | |
| 9 | 2023 | 1 |
About Mengda Xu
Mengda Xu is a scholar working on Surgery, Epidemiology, Infectious Diseases, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 9 papers that have together received 959 indexed citations. Recurring topics across this work include Respiratory Support and Mechanisms (2 papers), COVID-19 Clinical Research Studies (2 papers), Hydrogen's biological and therapeutic effects (1 paper), Long-Term Effects of COVID-19 (1 paper), COVID-19 diagnosis using AI (1 paper), Postharvest Quality and Shelf Life Management (1 paper), Cholesterol and Lipid Metabolism (1 paper) and Sphingolipid Metabolism and Signaling (1 paper). The work is most often cited by research in Infectious Diseases (643 citations), Neurology (341 citations), Critical Care and Intensive Care Medicine (53 citations), Dermatology (47 citations) and Epidemiology (174 citations). Mengda Xu has collaborated with scholars based in China. Frequent co-authors include Bixi Li, Xiaoyang Song, Xiang Zhou, Fang Liu, Juan Wu, Li Lin, Changli Wang, Xiaoming Deng, Jinjun Bian and Zhengyu Jiang. Their work appears in journals such as Scientific Reports, Virology Journal, Experimental & Molecular Medicine, Journal of Molecular Histology and CyTA - Journal of Food.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.